Archean Chemical Q1 FY26 Earnings Analysis

- **Bromine volumes for FY '26:** Targeted increase to 22,000 - 25,000 tons (including captive consumption), surpassing FY '25 volumes of ~18,000 tons. - **Bromine derivatives:** Targeting at least 10,000 tons sales in FY '26, with a strong start of 500 tons sold in Q4 FY '25, indicating potential upside. - **Industrial Salt volumes for FY '26:** Expected to exceed 4 million tons, with capacity expanded to over 5 million tons annually after commissioning of additional washery. - **Revenue from Oren Hydrocarbons:** Estimated INR 150 crores for FY '26, with peak potential previously near INR 500 crores pre-troubles. - **Pricing outlook:** Salt prices largely stable with occasional minor drops; bromine pricing expected to maintain or modestly increase with long-term contracts priced about 20% below spot rates. - **Strategic growth:** Focus on bromine and derivatives expansion, plus new initiatives in semiconductor and energy storage sectors supporting long-term growth.

- Bromine volumes targeted to increase to 22,000-25,000 tons in FY '26, with growing demand and contracts underpinning confidence. - Bromine derivative business aims to achieve positive PAT this year, indicating expected profitability improvement. - Industrial salt volumes expected to maintain above 1 million tons per quarter with tight cost control sustaining contribution levels. - Sulphate of Potash plant scale-up anticipated to contribute meaningfully from second half FY '26. - Margins expected to improve as bromine derivative plant utilization rises beyond 50% in near term. - Modest capex planned (~INR 50-60 crores) for semiconductor project next year; focus on disciplined capital allocation. - Overall EBITDA margin stable around 35% in FY '25; efforts ongoing to sustain or improve through volume growth and cost management. - Net profit for FY '25 was INR 1,849.2 million with optimism on increasing top line and bottom line through volume growth, new products, and operational efficiencies.

- Bromine derivatives business: Total planned capex of around INR250 crores; INR160-170 crores already spent. Additional capex for flame retardant project within the original budget; commissioning expected by FY '26 end. - Oren Hydrocarbons: Acquisition cost approximately INR77 crores plus ~INR10 crores refurbishment. Total budgeted capex INR25-30 crores; no large incremental capex planned beyond this. - SOP (Sulphate of Potash) plant startup: Estimated capex of INR20-30 crores expected between now and September-October. - Semiconductor project: Land acquisition completed; major capex planned for next year, with INR50-60 crores capex possibly in FY '26. - Offgrid Energy Labs (zinc-bromide battery business): Progressing on site and vendor selection; no large capex currently. - Salt business: No major capex except for routine maintenance and operational scale-up.

- No specific mention of any new fundraising through debt or equity in the call transcript. - The company stated it remains a net debt-free entity with a strong balance sheet. - Capital allocation is described as disciplined, focusing on cautious and conservative use of cash. - Current and planned capital expenditures are funded within existing budgets (e.g., bromine derivatives project under INR250 crores, Oren Hydrocarbons refurbishment within INR25-30 crores budget). - No large incremental capex or new external financing planned outside these budgets. - Ongoing projects like the semiconductor initiative and energy storage are progressing with existing resources. - The management emphasizes vigilance and prudence in pursuing growth opportunities without indicating plans for fresh debt or equity raising.

- The transcript does not explicitly mention the current or expected order book or pending orders for Archean Chemical Industries Limited. - However, management highlighted strong contracts for bromine with visibility on growth for FY '26 (targeting 22,000 to 25,000 tons in sales). - Long-term bromine contracts continue without price reductions, indicating stability and ongoing demand. - Industrial salt sales have recovered strongly with volumes reaching 1.3 million tons in Q4 FY '25 and capacity expanded to over 5 million tons annually, supported by long-term customer contracts. - The derivatives business, though in early stages, shows promise with 500 MT sold in Q4 FY '25 and a target of 10,000 MT for FY '26. - Oren Hydrocarbons are operational in parts with revenues expected around INR 150 crores this year, indicating growing business from the acquired asset.